| Literature DB >> 12163211 |
Kenneth C H Fearon1, Alastair G W Moses.
Abstract
Cancer cachexia is a complex, multifactorial syndrome that results from a reduction in food intake, a variety of metabolic abnormalities (including hypermetabolism) or more often a combination of the two. Multiple mediator pathways including pro-inflammatory cytokines, neuroendocrine hormones and tumour-specific factors are involved. Therapy requires a multi-model approach that addresses both reduced food intake and metabolic change. Combination treatments such as nutritional support plus metabolic/inflammation modulation promise improved functional capacity and quality of life.Entities:
Mesh:
Year: 2002 PMID: 12163211 DOI: 10.1016/s0167-5273(02)00235-8
Source DB: PubMed Journal: Int J Cardiol ISSN: 0167-5273 Impact factor: 4.164